Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INOV

Inovalon (INOV) Stock Price, News & Analysis

Inovalon logo

About Inovalon Stock (NASDAQ:INOV)

Advanced Chart

Key Stats

Today's Range
$31.76
$31.89
50-Day Range
$40.66
$41.06
52-Week Range
$17.56
$41.06
Volume
728 shs
Average Volume
720,587 shs
Market Capitalization
$4.95 billion
P/E Ratio
93.80
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.

Receive INOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.

INOV Stock News Headlines

Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

INOV Stock Analysis - Frequently Asked Questions

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its quarterly earnings data on Wednesday, July, 28th. The technology company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to the consensus estimate of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%.

Inovalon (INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Top institutional shareholders of Inovalon include Luminist Capital LLC (0.02%) and Cetera Investment Advisers (0.01%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalon investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Moderna (MRNA), Meta Platforms (META) and PayPal (PYPL).

Company Calendar

Last Earnings
7/28/2021
Today
6/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Data Processing & Preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:INOV
Employees
1,836
Year Founded
N/A

Profitability

Trailing P/E Ratio
93.80
Forward P/E Ratio
53.15
P/E Growth
2.99
Net Income
$22.58 million
Pretax Margin
5.86%

Debt

Sales & Book Value

Annual Sales
$667.52 million
Cash Flow
$0.96 per share
Price / Cash Flow
33.35
Book Value
$4.94 per share
Price / Book
6.46

Miscellaneous

Free Float
78,011,000
Market Cap
$4.95 billion
Optionable
No Data
Beta
0.53

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:INOV) was last updated on 6/3/2025 by MarketBeat.com Staff
From Our Partners